Interleukin-10 (IL-10)- Pipeline Market Size | Growth Opportunities with Prominent Players, Top Regions and Applications

 Market Research Future (MRFR) has presented a detailed study into the global operations in the global interleukin market and an extensive analysis of the market’s pipeline. The report presents to readers a clear picture of the current operating conditions in the global interleukin market by detailing the various factors affecting the product pipeline in the market.

Interleukin is an anti-inflammatory cytokine with several varied functions in the immune system. It has a key function of stopping inflammation of immune cells by blocking the production of cytokines. The global interleukin market has grown rapidly over the last few years due to the growing awareness about the utility of interleukin-10 in the treatment of autoimmune diseases, in addition to other diseases such as cancer. The increasing prevalence of autoimmune diseases around the world has been a major driver for the global interleukin-10 market. The increasing prevalence of cancer has also helped the market achieve a steady growth rate. The interleukin-10 pipeline consists of nearly 20 molecules being studied upon at present. These include 9 molecules in the preclinical stage, 4 molecules in phase II, and 2 molecules in phase I. 

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/2640

Autoimmune diseases are also rising in prevalence, aided by lifestyle factors. Autoimmune diseases can have a significant impact on the quality of life of the patients, which have made them a major challenge in the medical research sector. Interleukin-10 treatments work on the fundamental properties of particles in the immune system, thus emerging as an effective method for treating autoimmune diseases. Interleukin-10-based treatments are also being researched to study their usability in the treatment of neurodegenerative diseases. Diseases such as Alzheimer’s have also emerged as a major challenge for the healthcare sector at present, due to the growing geriatric population around the world. This is also likely to remain a major driver for the interleukin-10 market over the forecast period.

Segmentation:

The key therapies studied in the report on the Interleukin-10 (IL-10)- Pipeline Market Size include AM-0010, ANV-103, AS-101, BT-063, DEKAVIL / F8-IL10, EG-12, LEO-32731, MK-1966, PD-2244, XT-101, XT-150, and others.

AM-0010 is a potential cancer therapy being researched and developed by ARMO BioSciences. This is intended to be used on pancreatic cancer and non-small-cell lung cancer, among others. The U.S. FDA and the EC have given AM-0010 the designation of an orphan drug for the treatment of pancreatic cancer. AM-0010 works by enhancing the activity of killer T-cells, which are responsible for recognizing and destroying cancer cells. 

ANV-103 is being researched for use in the treatment of autoimmune uveitis, which is an inflammation of the uvea, which is a pigmented layer in the eye. 

BT-063 is a monoclonal antibody being researched for use in the treatment of systemic lupus erythematosus (SLE). BT-063 is in the IIa phase of research. 

DEKAVIL/F8-IL10 is under research for inhibiting the progression of collagen-induced arthritis. Arthritis has emerged as a major chronic disease in developed regions of the world, making this avenue commercially lucrative. 

LEO-32731 is being researched for use in the treatment of psoriasis vulgaris. 

MK-1966 is another cancer therapy being researched for use against advanced malignancies. 

PD-2244 is under development as an anti-Alzheimer’s drug. It is also intended to be used against frontotemporal dementia. 

XT-101 is likely to be used for neuropathic pain indications. 

Competitive Analysis:

Leading players in the global interleukin-10 market include Pfizer Inc., Merck & Co. Inc., BioMAS Ltd., Leo Pharma, Intrexon Corporation, Xalud Therapeutics Inc., P2D Biosciences, Anvil Biosciences, EnGene Inc., and Biotest AG. 

Browse Complete Report with TOC at

https://www.marketresearchfuture.com/reports/interleukin-market-2640

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Cosmetic Dentistry Market Size By Application, Growth Potential, Price Trend & Forecast

  Market Highlights Cosmetic dentistry is the dental work that helps improve the look of a person's teeth. The treatment includes teeth whitening, straightening, reshaping, and realignment. There are several other cosmetic dental services, which include cosmetic gum surgery, tooth contouring and reshaping, tooth colored fillings, composite bonding, dental implants, and inlays and onlays. Technological advancements have also allowed the application of novel techniques. The high cost of dental imaging procedures and lack of reimbursement options hinder the growth of this market. The global cosmetic dentistry market is dominated by many key market players. These players are engaged in new product launches and tactical partnerships to brace their market position. For instance, in April 2017, Zimmer Biomet Holdings, Inc. announced the distribution of NovaBone Dental Putty in over 40 countries within the Middle East, Africa, Latin America, Asia-Pacific, and the selected markets in Europe
Read more

Brucellosis Treatment Market Insights by Trends, Growth, Scope, Size, Overall Analysis and Prognostication

  Market Highlights: Brucellosis is a zoonotic infection caused by the species of Brucella bacteria. The bacteria is transmitted from animals to humans through infected food products, direct contact with an infected animal, or inhalation of aerosols. The disease is known by many names, including Mediterranean fever, Malta fever, gastric remittent fever, and undulant fever. Usually, humans are accidental hosts, but brucellosis still continues to remain a major health concern worldwide. Brucellosis is a has a high degree of morbidity in humans worldwide. According to WHO data about 500,000 cases of this disease are registered in the world every year. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/5159 Usually, Brucella abortus is associated with the disease in cattle and bison, Brucella suis with the disease in swine, and Brucella melitensis with the disease in sheep and goats. Under appropriate conditions, brucellosis can be caused in one species b
Read more

Preclinical Imaging Market Dynamics, Developments, Potential Players & Worldwide Opportunities

  The global preclinical imaging market is growing pervasively, witnessing increasing consumption of imaging products in various modalities. Also, rising technological advances in the field of molecular imaging, alongside the growing demand for non-invasive small animal imaging techniques drives the growth of the market. Moreover, increasing funding to support preclinical researches is escalating the market growth to furthered height.  Request Sample Copy: https://www.marketresearchfuture.com/sample_request/7365 According to Market Research Future (MRFR), the global preclinical imaging market valuation had reached USD 2.01 BN in 2017, which is further expected to appreciate at 6.3% CAGR over the assessment period (2018 to 2023). The market has seen several innovative and easy-to-use imaging agents launches, which has undoubtedly helped in the growth of the market. Rising technological advancements are estimated to propel the growth of the market.  The growing prevalence of myriads of c
Read more